Cannabis Science

Cannabis Science, Inc. is a biotech company based in Irvine, California. The company was incorporated in 2009 and formerly traded under the ticker CBIS on the Over-The-Counter Bulletin Board until October 2019, when their SEC license was revoked.^[2]

Cannabis Science Inc.

Company type	Private
Industry	Pharmaceutical
Founded	2000 (as National Healthcare Technology), reestablished in 2009
Headquarters	Irvine, California, U.S.
Key people	Raymond C. Dabney (President, CEO, Co-Founder and Director) Robert Melamede (Co-Founder)[1]
Products	Pharmaceutical products
Website	cannabisscience.com

The company's stated goal was to obtain Food and Drug Administration (FDA) approval for cannabis-based medicines, with a focus on treating skin cancer (basal and squamous cell carcinomas),^[3] posttraumatic stress disorder^[4] and HIV.^[3] The FDA has not approved these treatments.^[5]